Analyst Rating Changes — Upgrades, Downgrades & Price Targets

34993 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Price-Target Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Oct 08 00:12 UTC	RVMD Revolution Medicines	◎ Target	Truist Financial	Gregory Renza ★★★☆☆ #1647	Buy	$239.00→ $240.00+0.4%
Oct 08 00:12 UTC	RPRX Royalty Pharma	◎ Target	Morgan Stanley	Terence Flynn ★★★☆☆ #1083	Overweight	$65.00→ $67.00+3.1%
Oct 08 00:12 UTC	RPM RPM International	◎ Target	Royal Bank Of Canada	Arun Viswanathan ★★★☆☆ #1952	Outperform	$128.00→ $120.00-6.2%
Oct 08 00:12 UTC	RPM RPM International	◎ Target	UBS Group	Joshua Spector ★★★☆☆ #1997	Buy	$142.00→ $128.00-9.9%
Oct 08 00:12 UTC	RPM RPM International	◎ Target	Citigroup	Patrick Cunningham ★★★☆☆ #1974	Buy	$128.00→ $116.00-9.4%
Oct 08 00:12 UTC	RGEN Repligen	◎ Target	Barclays	Luke Sergott ★★★★★ #57	Overweight	$175.00→ $225.00+28.6%
Oct 08 00:12 UTC	RGA Reinsurance Group of America	◎ Target	Barclays	Alex Scott ★★★★☆ #456	Overweight	$290.00→ $286.00-1.4%
Oct 08 00:12 UTC	REGN Regeneron Pharmaceuticals	◎ Target	Truist Financial	Gregory Renza ★★★☆☆ #1647	Buy	$772.00→ $780.00+1.0%
Oct 08 00:12 UTC	REGN Regeneron Pharmaceuticals	◎ Target	Morgan Stanley	Matthew Harrison not yet tracked	Equal Weight	$758.00→ $779.00+2.8%
Oct 08 00:12 UTC	RCL Royal Caribbean Cruises	◎ Target	Barclays	Brandt Montour ★★★☆☆ #2205	Overweight	$340.00→ $337.00-0.9%
Oct 08 00:12 UTC	RCKT Rocket Pharmaceuticals	◎ Target	Leerink Partners	Roanna Ruiz ★★☆☆☆ #2781	Market Perform	$7.00→ $4.00-42.9%
Oct 08 00:12 UTC	RCI.A Rogers Communications	◎ Target	Desjardins	firm only	Buy	C$58.00→ C$55.00-5.2%
Oct 08 00:12 UTC	QXO QXO	◎ Target	Royal Bank Of Canada	Mike Dahl not yet tracked	Outperform	$27.00→ $18.00-33.3%
Oct 08 00:12 UTC	QSR Restaurant Brands International	◎ Target	TD Cowen	Andrew M. Charles not yet tracked	Hold	$80.00→ $78.00-2.5%
Oct 08 00:12 UTC	QBR.A Quebecor	◎ Target	Desjardins	firm only	Buy	C$76.00→ C$74.00-2.6%
Oct 08 00:12 UTC	PRU Prudential Financial	◎ Target	Barclays	Alex Scott ★★★★☆ #456	Underweight	$92.00→ $96.00+4.3%
Oct 08 00:12 UTC	PRU Prudential Financial	◎ Target	Mizuho	Yaron Kinar ★★★★★ #165	Neutral	$113.00→ $109.00-3.5%
Oct 08 00:12 UTC	PRG PROG	◎ Target	Jefferies Financial Group	John Hecht ★★★☆☆ #1780	Buy	$60.00→ $50.00-16.7%
Oct 08 00:12 UTC	PPL Pembina Pipeline	◎ Target	Barclays	firm only	Overweight	C$69.00→ C$70.00+1.4%
Oct 08 00:12 UTC	PKG Packaging Corporation of America	◎ Target	Wells Fargo & Company	Gabe Hajde not yet tracked	Equal Weight	$246.00→ $245.00-0.4%
Oct 08 00:12 UTC	PJT PJT Partners	◎ Target	UBS Group	Michael Brown ★★★☆☆ #1460	Neutral	$176.00→ $165.00-6.2%
Oct 08 00:12 UTC	PII Polaris	◎ Target	Robert W. Baird	Craig Kennison ★☆☆☆☆ #2992	Neutral	$72.00→ $65.00-9.7%
Oct 08 00:12 UTC	PHIN PHINIA	◎ Target	UBS Group	Joseph Spak ★★★☆☆ #1645	Neutral	$80.00→ $68.00-15.0%
Oct 08 00:12 UTC	PGR Progressive	◎ Target	Barclays	Alex Scott ★★★★☆ #456	Overweight	$246.00→ $247.00+0.4%
Oct 08 00:12 UTC	PFG Principal Financial Group	◎ Target	Barclays	Alex Scott ★★★★☆ #456	Underweight	$92.00→ $86.00-6.5%
Oct 08 00:12 UTC	PENG Penguin Solutions	◎ Target	Barclays	Tom O'Malley not yet tracked	Underweight	$40.00→ $60.00+50.0%
Oct 08 00:12 UTC	PENG Penguin Solutions	◎ Target	Rosenblatt Securities	Kevin Cassidy ★★☆☆☆ #2661	Buy	$80.00→ $100.00+25.0%
Oct 08 00:12 UTC	PENG Penguin Solutions	◎ Target	Stifel Nicolaus	Brian Chin ★★☆☆☆ #2286	Buy	$75.00→ $85.00+13.3%
Oct 08 00:12 UTC	PENG Penguin Solutions	◎ Target	Needham & Company LLC	Matthew Calitri ★★★☆☆ #1163	Buy	$80.00→ $85.00+6.2%
Oct 08 00:12 UTC	PCRX Pacira BioSciences	◎ Target	Truist Financial	Les Sulewski ★★★★☆ #942	Buy	$30.00→ $31.00+3.3%
Oct 08 00:12 UTC	OPRT Oportun Financial	◎ Target	Jefferies Financial Group	John Hecht ★★★☆☆ #1780	Hold	$6.00→ $9.00+50.0%
Oct 08 00:12 UTC	ONC BeOne Medicines	◎ Target	Truist Financial	Gregory Renza ★★★☆☆ #1647	Buy	$418.00→ $420.00+0.5%
Oct 08 00:12 UTC	OABI OmniAb	◎ Target	Leerink Partners	Puneet Souda ★★★★★ #14	Outperform	$10.00→ $12.00+20.0%
Oct 08 00:12 UTC	NXT Nextpower	◎ Target	Citigroup	Vikram Bagri ★☆☆☆☆ #2951	Buy	$132.00→ $121.00-8.3%
Oct 08 00:12 UTC	NTRA Natera	◎ Target	Barclays	Luke Sergott ★★★★★ #57	Overweight	$340.00→ $475.00+39.7%
Oct 08 00:12 UTC	NSLR Neostellar Capital	◎ Target	BTIG Research	Marvin Fong ★★☆☆☆ #2762	Buy	$15.00→ $14.00-6.7%
Oct 08 00:12 UTC	NSC Norfolk Southern	◎ Target	Citigroup	Ariel Rosa ★★★☆☆ #1060	Neutral	$376.00→ $347.00-7.7%
Oct 08 00:12 UTC	NP Neptune Insurance	◎ Target	Mizuho	Yaron Kinar ★★★★★ #165	Neutral	$32.00→ $31.00-3.1%
Oct 08 00:12 UTC	NOW ServiceNow	◎ Target	Argus	Joseph Bonner ★★★☆☆ #1648	Buy	$134.00→ $170.00+26.9%
Oct 08 00:12 UTC	NG Novagold Resources	◎ Target	Morgan Stanley	Carlos De Alba ★★★☆☆ #2106	Overweight	$13.60→ $13.00-4.4%
Oct 08 00:12 UTC	NET Netcall	◎ Target	Canaccord Genuity Group	firm only	Buy	GBX 160→ GBX 170+6.2%
Oct 08 00:12 UTC	MU Micron Technology	◎ Target	DA Davidson	Gil Luria ★★★☆☆ #1744	Buy	$2,100.00→ $3,000.00+42.9%
Oct 08 00:12 UTC	MTD Mettler-Toledo International	◎ Target	Barclays	Luke Sergott ★★★★★ #57	Overweight	$1,575.00→ $1,700.00+7.9%
Oct 08 00:12 UTC	MRX Marex Group plc Ordinary Shares	◎ Target	Barclays	Benjamin Budish ★★★☆☆ #1179	Overweight	$86.00→ $92.00+7.0%
Oct 08 00:12 UTC	MRVL Marvell Technology	◎ Target	Wolfe Research	Chris Caso ★★★★☆ #333	Outperform	$280.00→ $375.00+33.9%
Oct 08 00:12 UTC	MRVL Marvell Technology	◎ Target	Stifel Nicolaus	Tore Svanberg ★★☆☆☆ #2512	Buy	$350.00→ $370.00+5.7%
Oct 08 00:12 UTC	MRVL Marvell Technology	◎ Target	UBS Group	Timothy Arcuri ★★★☆☆ #1759	Buy	$335.00→ $350.00+4.5%
Oct 08 00:12 UTC	MRVL Marvell Technology	◎ Target	Morgan Stanley	Joseph Moore ★★★☆☆ #1842	Equal Weight	$268.00→ $300.00+11.9%
Oct 08 00:12 UTC	MRVL Marvell Technology	◎ Target	Piper Sandler	David O'Connor ★★★★★ #149	Overweight	$270.00→ $400.00+48.1%
Oct 08 00:12 UTC	MRVL Marvell Technology	◎ Target	Wells Fargo & Company	Aaron Rakers ★★★★☆ #610	Overweight	$310.00→ $365.00+17.7%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Price-Target Changes

Frequently Asked Questions

Welcome to 13Foresight!